UCB, a global biopharmaceutical company, today announced positive topline data from the BE BOLD trial assessing BIMZELX® (bimekizumab) versus SKYRIZI® (risankizumab) in adults with active psoriatic ...

Chronic kidney disease is increasing in India and often goes unnoticed until late stages. Experts highlight the warning signs and preventive steps that can help protect kidney health ...

The Department of Health - Cordillera region urged residents anew to undergo testing for tuberculosis (TB) and avail of the government’s free medication to prevent the spread of the disease. “Wag ...

Understanding how aging reshapes the body and why physical function often declines over time has become a central focus of modern biomedical research. A new Yale School of Medicine (YSM) study, ...

For people who have recovered from diagnoses characterized by persistent fatigue, a new understanding of symptoms seems to have been key to recovery. This is the conclusion of a study from Linköping ...

A University of Calgary–led research team finds that only 7% of children infected with Shiga toxin–producing Escherichia coli (STEC) developed hemolytic uremic syndrome (HUS) during a 395-case ...